CFS Investment Advisory Services LLC Has $1.63 Million Stock Position in Cardinal Health, Inc. (NYSE:CAH)

CFS Investment Advisory Services LLC trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 1.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,784 shares of the company’s stock after selling 277 shares during the quarter. CFS Investment Advisory Services LLC’s holdings in Cardinal Health were worth $1,634,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Raymond James Trust N.A. boosted its holdings in shares of Cardinal Health by 19.0% during the third quarter. Raymond James Trust N.A. now owns 12,656 shares of the company’s stock worth $1,399,000 after purchasing an additional 2,018 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in shares of Cardinal Health by 2.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock worth $162,976,000 after purchasing an additional 33,388 shares during the period. Pacer Advisors Inc. boosted its holdings in shares of Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock worth $474,203,000 after purchasing an additional 191,568 shares during the period. Trustmark National Bank Trust Department boosted its holdings in shares of Cardinal Health by 1.3% during the third quarter. Trustmark National Bank Trust Department now owns 22,413 shares of the company’s stock worth $2,477,000 after purchasing an additional 279 shares during the period. Finally, Intech Investment Management LLC boosted its holdings in shares of Cardinal Health by 1.1% during the third quarter. Intech Investment Management LLC now owns 148,552 shares of the company’s stock worth $16,418,000 after purchasing an additional 1,633 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $123.30 on Friday. The firm has a market capitalization of $29.84 billion, a PE ratio of 23.99, a price-to-earnings-growth ratio of 1.48 and a beta of 0.60. The company’s fifty day moving average price is $113.72 and its two-hundred day moving average price is $105.70. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $126.14.

Cardinal Health (NYSE:CAH) last posted its earnings results on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.26. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The business had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. During the same quarter in the prior year, the firm earned $1.73 EPS. The firm’s quarterly revenue was down 4.3% compared to the same quarter last year. Analysts predict that Cardinal Health, Inc. will post 7.83 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.64%. The ex-dividend date of this dividend is Thursday, January 2nd. Cardinal Health’s payout ratio is 39.30%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CAH. UBS Group raised their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a report on Monday, November 4th. Robert W. Baird boosted their target price on shares of Cardinal Health from $130.00 to $137.00 and gave the stock an “outperform” rating in a research report on Thursday, August 15th. Mizuho boosted their target price on shares of Cardinal Health from $110.00 to $120.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. StockNews.com downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $123.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.